| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.33 | 1e-07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.32 | 5e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.29 | 3e-14 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.28 | 3e-08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.28 | 9e-07 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-13 |